Cargando…

Targeting spike glycans to inhibit SARS-CoV2 viral entry

Mostrar otras versiones (1)

SARS-CoV-2 spike harbors glycans which function as ligands for lectins. Therefore, it should be possible to exploit lectins to target SARS-CoV-2 and inhibit cellular entry by binding glycans on the spike protein. Burkholderia oklahomensis agglutinin (BOA) is an antiviral lectin that interacts with v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guseman, Alex J., Rennick, Linda J., Nambulli, Sham, Roy, Chandra N., Martinez, David R., Yang, Darian T., Bhinderwala, Fatema, Vergara, Sandra, Schaefer, Alexandra, Baric, Ralph S., Ambrose, Zandrea, Duprex, W. Paul, Gronenborn, Angela M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2023
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515186/ https://www.ncbi.nlm.nih.gov/pubmed/37695910 http://dx.doi.org/10.1073/pnas.2301518120

Ejemplares similares

Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry
por: Guseman, Alex J., et al.
Publicado: (2022)

Abstract 1509: Targeting Spike Glycans to Inhibit SARS-CoV-2 Viral Entry
por: Guseman, Alex, et al.
Publicado: (2023)

Developing lectins as inhibitors of SARS-CoV2
por: Guseman, Alex J., et al.
Publicado: (2022)

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
por: McCarthy, Kevin R., et al.
Publicado: (2021)

Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry
por: Shang, Jian, et al.
Publicado: (2020)

Chronic Infection of Domestic Cats with Feline Morbillivirus, United States
por: Sharp, Claire R., et al.
Publicado: (2016)

Idiosyncratic Mòjiāng virus attachment glycoprotein directs a host-cell entry pathway distinct from genetically related henipaviruses
por: Rissanen, Ilona, et al.
Publicado: (2017)

Mapping the evolutionary trajectories of morbilliviruses: what, where and whither
por: Nambulli, Sham, et al.
Publicado: (2016)

Coronavirus Spike Proteins in Viral Entry and Pathogenesis
por: Gallagher, Thomas M., et al.
Publicado: (2001)

Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses
por: Nambulli, Sham, et al.
Publicado: (2021)

Glycan reactive anti-HIV-1 antibodies bind the SARS-CoV-2 spike protein but do not block viral entry
por: Mannar, Dhiraj, et al.
Publicado: (2021)

Multiplexed Metagenomic Deep Sequencing To Analyze the Composition of High-Priority Pathogen Reagents
por: Wilson, Michael R., et al.
Publicado: (2016)

FeMV is a cathepsin-dependent unique morbillivirus infecting the kidneys of domestic cats
por: Nambulli, Sham, et al.
Publicado: (2022)

Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
por: Belouzard, Sandrine, et al.
Publicado: (2012)

CG Dinucleotide Removal in Bioluminescent and Fluorescent Reporters Improves HIV-1 Replication and Reporter Gene Expression for Dual Imaging in Humanized Mice
por: Roy, Chandra N., et al.
Publicado: (2021)

Spike Gene Determinants of Mouse Hepatitis Virus Host Range Expansion
por: McRoy, Willie C., et al.
Publicado: (2006)

Omicron spike protein: a clue for viral entry and immune evasion
por: Behrens, G. M. N., et al.
Publicado: (2022)

Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration
por: Yang, Qi, et al.
Publicado: (2020)

Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
por: Derking, Ronald, et al.
Publicado: (2021)

Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics
por: Newby, Maddy L., et al.
Publicado: (2023)

Viral Interactions with Glycans
por: Suenaga, Tadahiro, et al.
Publicado: (2014)

Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

Concerted hinge motions in SARS-CoV-2 spike modulated by glycan-glycan and glycan-lipid interactions
por: Kapoor, Karan, et al.
Publicado: (2022)

Sustained Replication of Synthetic Canine Distemper Virus Defective Genomes In Vitro and In Vivo
por: Tilston-Lunel, Natasha L., et al.
Publicado: (2021)

Use of pediatric thymus to humanize mice for HIV-1 mucosal transmission
por: Roy, Chandra N., et al.
Publicado: (2023)

Characterization of CCoV-HuPn-2018 spike protein-mediated viral entry
por: Liu, Yongmei, et al.
Publicado: (2023)

Development and Validation of Fluorinated, Aromatic Amino Acid Parameters for Use with the AMBER ff15ipq Protein Force Field
por: Yang, Darian T., et al.
Publicado: (2022)

Ligand-Capped Cobalt(II) Multiplies the Value of the Double-Histidine Motif for PCS NMR Studies
por: Zhu, Wenkai, et al.
Publicado: (2023)

Fluorescent glycan fingerprinting of SARS2 spike proteins
por: Wu, Zhengliang L., et al.
Publicado: (2021)

Role for N-glycans and calnexin-calreticulin chaperones in SARS-CoV-2 Spike maturation and viral infectivity
por: Yang, Qi, et al.
Publicado: (2022)

Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
por: Budhadev, Darshita, et al.
Publicado: (2023)

Metabolic profiling of historical and modern wheat cultivars using proton nuclear magnetic resonance spectroscopy
por: Poudel, Rachana, et al.
Publicado: (2021)

Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
por: Kastenhuber, Edward R, et al.
Publicado: (2022)

Inoculation of raccoons with a wild-type-based recombinant canine distemper virus results in viremia, lymphopenia, fever, and widespread histological lesions
por: Roelofs, Dagmar, et al.
Publicado: (2023)

Glycan–protein interactions in viral pathogenesis
por: Raman, Rahul, et al.
Publicado: (2016)

Binding of the SARS-CoV-2 spike protein to glycans
por: Hao, Wei, et al.
Publicado: (2021)

The roles of glycans in the SARS-CoV-2 spike protein
por: Casalino, Lorenzo, et al.
Publicado: (2022)

Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection
por: Dong, Wenjuan, et al.
Publicado: (2023)

SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patients
por: Klimstra, William B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_64s48jnisannu9k494e9pvvs2k